# Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%

> **NCT03519386** · PHASE3 · COMPLETED · sponsor: **Glaukos Corporation** · enrollment: 590 (actual)

## Conditions studied

- Glaucoma, Open-Angle
- Ocular Hypertension

## Interventions

- **COMBINATION_PRODUCT:** G2-TR intraocular implant containing travoprost
- **DRUG:** Sham surgery + active-comparator eye drops

## Key facts

- **NCT ID:** NCT03519386
- **Lead sponsor:** Glaukos Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-26
- **Primary completion:** 2022-04-05
- **Final completion:** 2024-04-02
- **Target enrollment:** 590 (ACTUAL)
- **Last updated:** 2024-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03519386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03519386, "Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03519386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*